Follicle Stimulating Hormone clinical trials
Also written FSH.
Its developmentBy Glycotope, IBSA Institut Biochimique and Hamad Medical, step by step6 company-led studies, furthest phase 4: when each phase was reached, its deals, target and what is ahead.Counted the way a researcher would: Follicle Stimulating Hormone with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.
This browser remembers your choice.
How each study uses Follicle Stimulating Hormone is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Follicle Stimulating Hormone studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 29 Sept 1997 · GONAL-F · BLA 020378 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
23 studies that test it; most in 2011 (3)
| Year | Studies |
|---|---|
| 2000 | 1 |
| 2003 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2011 | 3 |
| 2013 | 3 |
| 2014 | 2 |
| 2015 | 2 |
| 2017 | 2 |
| 2020 | 2 |
| 2024 | 2 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 6 · Other 17
Glycotope GmbH (3) · IBSA Institut Biochimique SA (2) · Cairo University (2) · Hospital de Cruces (1) · ART Fertility Clinics LLC (1) · Istanbul University (1) · Instituto Valenciano de Infertilidad, IVI VALENCIA (1) · Yale University (1)
Often tested with
Tested in the same studies.
Letrozole (3) · Clomiphene (2) · Antioxidants (1) · Luteinizing Hormone (1)
Related medicines
As reviewed, each with the page that says it.
- One of Hormones source
- Follitropin delta is a recombinant medicine of it, counted here with related medicines source
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 2
Studies that test Follicle Stimulating Hormone.
- Dec 2026Effects of LH and FSH on Metabolic Regulation in Cumulus CellsNot applicable · Kaohsiung Veterans General Hospital.
- Oct 2027Comparative Efficacy of Antioxidants Alone Versus Combined Therapy With SERMs or FSH in Normogonadotropic Idiopathic OAT Patients: A Randomized Controlled TrialPhase 4 · Hamad Medical Corporation
Studies
Open first, then newest update. How each study uses Follicle Stimulating Hormone is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 23
- Use of Pulsatile Intravenous FSH to Mitigate Reprometabolic SyndromeRecruitingPhase 1University of Colorado, DenverNCT06414096Written as Follicle Stimulating HormoneHow we know
- Comparative Efficacy of Antioxidants Alone Versus Combined Therapy With SERMs or FSH in Normogonadotropic Idiopathic OAT Patients: A Randomized Controlled TrialNot yet recruitingPhase 4Hamad Medical CorporationNCT07862725Written as Antioxidants + FSHHow we know
- Effects of LH and FSH on Metabolic Regulation in Cumulus CellsRecruitingNot applicableKaohsiung Veterans General Hospital.NCT06803199Written as FSH and LHHow we know
- FSH in Azoospermic MenWithdrawnPhase 4Azienda Sanitaria Locale BariNCT02275169Written as Follicle Stimulating HormoneHow we know
- 150 IU vs. 225 IU FSH in Normal Responders: The OPTIMAL-DOSE TrialWithdrawnPhase 3American Hospital 2 KosovoNCT07346235Written as Follicle-stimulating hormone (FSH)How we know
- Influence of FSH/LH Ratio in Controlled Ovarian StimulationCompletedEarly Phase 1Hospital de CrucesNCT02994550Written as FSH/LHHow we know
- Single Dose FSH-GEX™ in Healthy VolunteersCompletedPhase 1Glycotope GmbHNCT01354886Written as FSH-GEX™How we know
- Multiple Dose FSH-GEX(TM) in Healthy VolunteersCompletedPhase 1Glycotope GmbHNCT01477073Written as FSH-GEX™How we know
- Efficacy and Safety of FSH-GEX™ in Comparison With 150 IU Gonal-f®CompletedPhase 2Glycotope GmbHNCT01794208Written as Follitropin EpsilonHow we know
- Step Down FSH Approach and Late Follicular Phase in Progesterone LevelCompletedEarly Phase 1ART Fertility Clinics LLCNCT03356964Written as follicle stimulating hormoneHow we know
- Effects of FSH on Endothelial Function (FEND)Status unknownPhase 4Federico II UniversityNCT04430621Written as Follicle Stimulating HormoneHow we know
- FSH Followed by HMG vs FSH Plus HMG in IVFStatus unknownPhase 4Mansoura UniversityNCT04385342Written as FSHHow we know
- Immunogenicity of Repeated Follicle Stimulating Hormone (FSH) Stimulation CyclesCompletedPhase 3IBSA Institut Biochimique SANCT01785095Written as FSH (Follicle Stimulating Hormone)How we know
- Comparison Between Laparoscopic Ovarian Diathermy and Urinary Purified FSH in Women With Clomiphene Citrate Resistant Polycystic Ovarian Syndrome.Status unknownPhase 3Cairo UniversityNCT02304536Written as FSHHow we know
- Comparison Between Letrozole and Urinary Purified FSH in Women With Clomiphene Citrate Resistant Polycystic Ovarian Syndrome.CompletedPhase 3Cairo UniversityNCT02304107Written as FSHHow we know
- Outcome of Three Controlled Ovarian Hyperstimulation Protocols in Poor Responding Infertility PatientsCompletedNot applicableIstanbul UniversityNCT02293668Written as FSH 225IU and hMG 225IUHow we know
- Efficacy of Ovarian Stimulation Based on FSHR Genotype StatusSuspendedPhase 3Medical University of ViennaNCT00749853Written as follicle stimulating hormoneHow we know
- Basal Androgens and LH Needing for Ovarian Stimulation for in Vitro FertilizationCompletedPhase 3Instituto Valenciano de Infertilidad, IVI VALENCIANCT01563809Written as FSH+LHHow we know
- Efficacy and Tolerability of Human FSH Versus Recombinant FSH (Follitropin Alpha) in ICSI.CompletedPhase 3IBSA Institut Biochimique SANCT00335725Written as Follicle Stimulating HormoneHow we know
- Assessment of Multiple Intrauterine Gestations From Ovarian StimulationCompletedPhase 3Yale UniversityNCT01044862Written as Follicle Stimulating Hormone (gonadotropin)How we know
See all 23 studies that test Follicle Stimulating Hormone →
Given beside what is tested · 3 — Follicle Stimulating Hormone is usual care or a partner of the new treatment
- Corifollitropin Alfa in Participants Undergoing Repeated Controlled Ovarian Stimulation (COS) Cycles Using a Multiple Dose Gonadatropin Releasing Hormone (GnRH) Antagonist Protocol (Study 38825)(P05714)CompletedPhase 3Organon and CoNCT00696878Written as FSHHow we know
- Human Growth Hormone Pre-treatment for 6 Weeks Prior to Ovulation Induction for IVFStatus unknownPhase 1/2Center for Human ReproductionNCT02179255Written as Follicle Stimulating HormoneHow we know
- Phase 3 Trial to Evaluate the Efficacy and Safety of COL-1620 Vaginal Progesterone GelCompletedPhase 3Merck KGaA, Darmstadt, GermanyNCT01863680Written as Follicle-stimulating hormone (FSH)How we know
As the comparator · 2 — what is tested is compared with Follicle Stimulating Hormone
- Corifollitropin Alfa Versus Recombinant Follicle Stimulating Hormone (FSH) in Ovarian Stimulation of Women Undergoing in Vitro FertilisationCompletedPhase 1/2National and Kapodistrian University of AthensNCT01319695Written as recombinant follicle stimulating hormone (FSH)How we know
- Luteinizing Hormone (LH) Supplementation in Gonadotropin-releasing Hormone (GnRH) Antagonist CyclesCompletedPhase 3Instituto Valenciano de Infertilidad, IVI VALENCIANCT01037699Written as rFSH: Follicle Stimulating HormoneHow we know
What changed recently
From the registry's own updates since Oct 20, 2026.
Stopped2
- FSH in Azoospermic MenWithdrawnOct 29, 2026NCT02275169
- 150 IU vs. 225 IU FSH in Normal Responders: The OPTIMAL-DOSE TrialWithdrawnOct 29, 2026NCT07346235
Codes
What other systems call Follicle Stimulating Hormone · ClinicalTrials.gg INT007526
- MeSH (NLM) D005640Follicle Stimulating HormoneOne source ClinicalTrials.gov
- RxNorm 227518One source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D005640 | Follicle Stimulating Hormone | One source ClinicalTrials.gov |
| RxNorm | 227518 | — | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.